SAB Biotherapeutics Inc. (SABSW)
NASDAQ: SABSW
· Real-Time Price · USD
0.02
-0.02 (-48.98%)
At close: Jun 09, 2025, 11:03 AM
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending March 31, 2025, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
1.32M
Revenue Growth
-40.94%
Price / Sales Ratio
26.54
Revenue / Employee
20.99K
Employees
63
Market Cap
220.21K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.32M | -40.94% |
| Dec 31, 2023 | 2.24M | -90.63% |
| Dec 31, 2022 | 23.9M | -60.73% |
| Dec 31, 2021 | 60.88M | +10.21% |
| Dec 31, 2020 | 55.24M | n/a |